Colour vision defects in occupational chronic solvent encephalopathy

Human and Experimental Toxicology

Volumn 26, Issue 4, 2007, Pages 375-383

  Päällysaho, Juha ^a   Näsänen, Risto ^a   Mäntyjärvi, Maija ^a   Kaukiainen, Ari ^a   Sainio, Markku ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Colour vision; Occupational chronic solvent encephalopathy; Toxic encephalopathy; Visual functions

Indexed keywords

SOLVENT;

ADULT; BRAIN CORTEX; BRAIN DISEASE; COLOR VISION; COLOR VISION DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL;

AGED; BRAIN DISEASES; CHRONIC DISEASE; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; EYE; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OCCUPATIONAL EXPOSURE; SOLVENTS;

EID: 34248567825     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107076820     Document Type: Conference Paper

References (50)

1. White RF, Proctor SP. Solvents and neurotoxicity. Lancet 1997; 349: 1239-1243.
2. Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. J Occup Med 1994; 36: 1079-1092.
3. Reinvang I, Borchgrevink HM, Aaserud O, Lie V, Malt UF, Nakstad P, Larsson PG, Gjerstad L. Neuropsychological findings in a non-clinical sample of workers exposed to solvents. J Neurol Neurosurg Psychiatry 1994; 57: 614-616.
4. Edling C, Ekberg K, Ahlborg G Jr, Alexandersson R, Barregard L, Ekenvall L, Nilsson L, Svensson BG. Long-term follow up of workers exposed to solvents. Br J Ind Med 1990; 47: 75-82.
5. van der Hoek JA, Verberk MM, Hageman G. Criteria for solvent-induced chronic toxic encephalopathy: a systematic review. Int Arch Occup Environ Health 2000; 73: 362-368.
6. Juntunen J. Neurotoxic syndromes and occupational exposure to solvents. Environ Res 1993; 60: 98-111.
7. Ridgway P, Nixon TE, Leach JP. Occupational exposure to organic solvents and long-term nervous system damage detectable by brain imaging, neurophysiology or histopathology. Food Cheam Toxicol 2003; 41: 153-187.
8. Thuomas KA, Moller C, Odkvist LM, Flodin U, Dige N. MR imaging in solvent-induced chronic toxic encephalopathy. Acta Radiol 1996; 37: 177-179.
9. Heuser G, Mena I, Alamos F. NeuroSPECT findings in patients exposed to neurotoxic chemicals. Toxicol Ind Health 1994; 10: 561-571.
10. Haut MW, Leach S, Kuwabara H, Whyte S, Callahan T, Ducatman A, Lombardo LJ, Gupta N. Verbal working memory and solvent exposure: a positron emission tomography study. Neuropsychology 2000; 14: 551-558.
11. Geller AM, Hudnell HK. Critical issues in the use and analysis of the Lanthony Desaturate Color Vision test. Neurotoxicol Teratol 1997; 19: 455-465.
12. Gobba F, Cavalleri A. Color vision impairment in workers exposed to neurotoxic chemicals. Neurotoxicology 2003; 24: 693-702.
13. Iregren A, Andersson M, Nylen P. Color vision and occupational chemical exposures: I. An overview of tests and effects. Neurotoxicology 2002; 23: 719-733.
14. Paramei GV, Meyer-Baron M, Seeber A. Impairments of colour vision induced by organic solvents: a meta-analysis study. Neurotoxicology 2004; 25: 803-816.
15. Gobba F. Occupational exposure to chemicals and sensory organs: a neglected research field. Neurotoxicology 2003; 24: 675-691.
16. Baelum J, Andersen IB, Lundqvist GR, Molhave L, Pedersen OF, Vaeth M, Wyon DP. Response of solvent-exposed printers and unexposed controls to six-hour toluene exposure. Scand J Work Environ Health 1985; 11: 271-280.
17. Russell RM, Carney EA, Feiock K, Garrett M, Karwoski P. Acute ethanol administration causes transient impairment of blue-yellow color vision. Alcohol Clin Exp Res 1980; 4: 396-399.
18. Zrenner E, Riedel KG, Adamczyk R, Gilg T, Liebhardt E. Effects of ethyl alcohol on the electrooculogram and color vision. Doc Ophthalmol 1986; 63: 305-312.
19. Mergler D, Huel G, Bowler R, Frenette B, Cone J. Visual dysfunction among former microelectronics assembly workers. Arch Environ Health 1991; 46: 326-334.
20. Donoghue AM, Dryson EW, Wynn-Williams G. Contrast sensitivity in organic-solvent-induced chronic toxic encephalopathy. J Occup Environ Med 1995; 37: 1357-1363.
21. Näsänen R, Kaukiainen A, Hero V, Päällysaho J, Müller K, Hari R, Akila R, Sainio M. Effects of long-term occupational solvent exposure on contrast sensitivity and performance in visual search. Environ Toxicol Pharmacol 2005; 19: 497-504.
22. Mäntyjärvi M. Normal test scores in the Farnsworth-Munsell 100 hue test. Doc Ophthalmol 2001; 102: 73-80.
23. Birch J. Diagnosis of Defective Colour Vision 2nd edition. Oxford: Butterworth-Heinemann, 2001. 51-85, 108-128.
24. Dain SJ. Clinical colour vision tests - invited review. Clin Exp Optom 2004; 87: 276-293.
25. Vingrys AJ, King-Smith PE. A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci 1988; 29: 50-63.
26. Allan D. Fourier analysis and the Famsworth-Munsell 100-Hue test. Ophthalmic Physiol Opt 1985; 5: 337-342.
27. Benzschawel T. Computerized analysis of the Farnsworth-Munsell 100-Hue test. Am J Optom Physiol Opt 1985; 62: 254-264.
28. Farnsworth D. The Farnsworth-Munsell 100-hue test for the examination of color discrimination manual. Baltimore, Munsell Color Co., 1957: 1-7.
29. Smith VC, Pokorny J, Pass AS. Color-axis determination on the Farnsworth-Munsell 100-hue test. Am J Ophthalmol 1985; 100: 176-182.
30. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-Hue test scores. Am J Ophthalmol 1982; 93: 635-642.
31. Dain SJ, Birch J. An averaging method for the interpretation of the Farnsworth-Munsell 100 hue test. Br J Physiol Opt 1987; 7: 267-280.
32. Kaukiainen A, Vehmas T, Rantala K, Nurminen M, Martikainen R, Taskinen H. Results of common laboratory tests in solvent-exposed workers. Int Arch Occup Environ Health 2004; 77: 39-46.
33. Farnsworth D. The Farnsworth-Munsell 100 hue and dichotomous tests for colour vision. J Opt Soc Am 1943; 33: 568-578.
34. Kinnear PR. Proposals for scoring and assessing the 100-Hue test. Vision Res 1970; 10: 423-433.
35. Chang YC. Patients with n-hexane induced polyneuropathy: a clinical follow up. Br J Ind Med 1990; 47: 485-489.
36. Raitta C, Seppäläinen AN, Huuskonen MS. N-hexane maculopathy in industrial workers. Graefes Arch Clin Exp Ophthalmol 1978; 209: 99-110.
37. Raitta C, Teir H, Tolonen M, Nurminen M, Helpiö E, Malmström S. Impaired color discrimination among viscose rayon workers exposed to carbon disulfide. J Occup Med 1981; 23: 189-192.
38. Vanhoorne M, De Rouck A, Bacquer D. Epidemiological study of the systemic ophthalmological effects of carbon disulfide. Arch Environ Health 1996; 51: 181-188.
39. Horan JM, Kurt TL, Landrigan PJ, Melius JM, Singal M. Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): a new occupational neuropathy. Am J Public Health 1985; 75: 513-517.
40. Mergler D, Belanger S, De Grosbois S, Vachon N. Chromal focus of acquired chromatic discrimination loss and solvent exposure among printshop workers. Toxicology 1988; 49: 341-348.
41. Merigan WH. Chromatic and achromatic vision of macaques: role of the P pathway. J Neurosci 1989; 9: 776-783.
42. Merigan WH, Katz LM, Maunsell JH. The effects of parvocellular lateral geniculate lesions on the acuity and contrast sensitivity of macaque monkeys. J Neurosci 1991; 11: 994-1001.
43. Schaumburg HH, Spencer PS. Environmental hydrocarbons produce degeneration in cat hypothalamus and optic tract. Science 1978; 199: 199-200.
44. Schiller PH, Logothetis NK, Charles ER. Role of the color-opponent and broad-band channels in vision. Vis Neurosci 1990; 5: 321-346.
45. Merigan WH, Maunsell JH. How parallel are the primate visual pathways? Annu Rev Neurosci 1993; 16: 369-402.
46. Lee BB. Paths to colour in the retina - invited review. Clin Exp Optom 2004; 87: 239-248.
47. Martin PR. Colour through the thalamus - invited review. Clin Exp Optom 2004; 87: 249-257.
48. Skoog K-O, Nilsson SEG. Changes in the c-wave of the electroretinogram and in the standing potential of the eye after small doses of toluene and styrene. Acta Ophthalmol. (Copenh.) 1981; 59: 71-79.
49. Beauchamp MS, Haxby JV, Jennings JE, DeYoe EA. An fMRI version of the Farnsworth-Munsell 100-Hue test reveals multiple color-selective areas in human ventral occipitotemporal cortex. Cereb Cortex 1999; 9: 257-263.
50. Beauchamp MS, Haxby JV, Rosen AC, DeYoe EA. A functional MRI case study of acquired cerebral dyschromatopsia. Neuropsychologia 2000; 38: 1170-1179.